ArticleClinical endocrinology2022

Ovarian response to follicle-stimulating hormone in women with polycystic ovary syndrome is diminished compared to ovulatory controls.

Tracy N H Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.